AMO 5G femtosecond laser cleared by FDA

Article

The FDA has cleared the iFS Advanced Femtosecond Laser (AMO), which is now available for order.

The FDA has cleared the iFS Advanced Femtosecond Laser (AMO), which is now available for order.

The fifth generation laser, which can cut a corneal flap within 10 seconds, includes IntraLase-Enabled Keratoplasty (IEK), and has a higher repetition rate and tighter spot separation than earlier models. It has a unique inverted bevel-in-side cut angle to improve the biomechanical stability of postoperative corneas, and can create an elliptical flap to increase the number of surgical options.

The iFS laser - part of AMO's proprietary iLASIK technology suite - has an ergonomic design, new contemporary user interface and high-resolution digital video microscope, all designed to increase surgeon comfort and ease of operating, enhancing the outcome for the patient.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.